Recombinant CD38 (Daratumumab Biosimilar) antibody
Reactivity: Human
ELISA, FACS, SPR, Func, BLI
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all CD38 (Daratumumab Biosimilar) products
- CD38 (Daratumumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Human
- Expression System
- CHO Cells
-
Clonality
- Monoclonal
-
Conjugate
- This CD38 (Daratumumab Biosimilar) antibody is un-conjugated
- Application
- ELISA, Flow Cytometry (FACS), Surface Plasmon Resonance (SPR), Functional Studies (Func), Bio-Layer Interferometry (BLI)
- Purpose
- Anti-CD38 Reference Antibody (daratumumab)
- Characteristics
- Anti-CD38 Reference Antibody (daratumumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.34 kDa.
- Purity
- >95 %
- Isotype
- IgG1
-
anti-CD38 (Daratumumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Human Monoclonal unconjugated Recombinant Antibody
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Comment
-
Conditions: Multiple Myeloma
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- 1 mg/mL
- Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
- Storage
- 4 °C,-80 °C
- Storage Comment
- +4°C,-80°C
-
- Target
- CD38 (Daratumumab Biosimilar)
- Abstract
- CD38 (Daratumumab Biosimilar) Products
- Target Type
- Biosimilar
- Background
- Synonyms: cADPr hydrolase 1, T10
- Molecular Weight
- 145.34 kDa
- UniProt
- P28907
-
You are here:
